Meta shares plunge after tax charge and higher costs warning
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Carlsberg's Q3 revenue rises 17.8% driven by acquisitions, but organic revenue and volumes decline amid challenging market conditions.
Meta shares plunge after tax charge and higher costs warning
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Carlsberg's Q3 revenue rises 17.8% driven by acquisitions, but organic revenue and volumes decline amid challenging market conditions.
